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ANTICHOLINERGICS
Detrusor overactivity
involuntary detrusor contractions during filling
ICCS Standardization Report on Urodynamic Studies of the Lower Urinary Tract: Neurourology and
Urodynamics 34: 640-647 (2015)
– 10% in normal children
– >50% in children with VUR
Symptoms:
Urgency Urge-incontinence
Frequency Holding maneuvers
OAB ?
Uroflow
OAB ?
NMNE ?
Monosymptomatic nocturnal enuresis: 
bedwetting without any other LUT symptoms
NMNE : Bedwetting + LUTS
Urgency         
Frequency
(Urge-) incontinence
Holding maneuvers
Infrequent voiding     postponing
Recurrent lower urinary tract infections
Abnormal voiding (Dysfunctional /obstructive)
Associated constipation 
Urotherapy
Antimuscarinics
Α-blockers:
– Doxazosin, tamsulosin, terazosin
Tricyclic antidepressant: imipramine
Β3-adrenoreceptor agonist
– Betmiga
Botulinum toxin
Neuromodulation
Reuptake inhibitor of serotonin and norepinephrine
– Duloxetine
– Reboxitine
TREATMENT OF NE AND NMNE ?
Blocking the binding of acetylcholine at the muscarinic receptors (M3
=> bladder relaxation
ANTIMUSCARINICS ?
EBM in NMNE? 
Lower succes-rates than in adults
Oxybutinin
High SAE in children with ADHD
T1/2…. : Doses !  
TREATMENT OF NE AND NMNE ?
Only oxybutinin is FDA approved for 
treatment in children
• Disadvantage: multiple side effects (4x more than in adults)
– Dry mouth (17-97%)
– Constipation (4-50%)
– Blurred vision (3-24%)
– Behavior and concentration problems
– Headache
– Fascial flushes
– Heat stroke
– Tachycardia
=>  10 % stops treatment
ANTIMUSCARINICS ?
Oxybutinin:
– To bypass the first pass metabolism in the 
liver:
• Oxybutinin ER
• Transdermal patch
• Intravesical oxybutinin
– Recommended daily dose: 0,3 mg/kg body 
weight
ANTIMUSCARINICS ?
Medication used in adults and not registered 
for children:
• Selective M3 bladder specific antimuscarinics
– Tolterodine
– Solifenacine
– Fesoterodine
Less side 
effects
ANTIMUSCARINICS ?
• Tolterodine (Detrusitol):
– Well tolerated in children
– Doses: 1mg twice daily (Hjalmas)
• = efficacy as 2mg
• < advers events with 1mg
– Effective in:
• Non-neurogenic overactive detrusor
• Neurogenic overactive detrusor
ANTIMUSCARINICS ?
• Solifenacine: (vesicare)
– Daily doses: 5mg
– Hoebeke et al. illustrated the safety and efficacy of solifenacin 5 mg daily in 
children suffering therapy resistant overactive bladder. The overall efficacy was 
85%
– Nadau et al. high subjective and objective succesrates in neurogenic detrusor 
overactivity and refractory detrusor overactivity
• Fesoterodine: (Toviaz)
– Malhotra et al. Oral administration in children > 25 kg with overactive detrusor or 
neurogenic detrusor overactivity produced steady-state plasma 5-hydroxyl-
methyltolterodine exposures similar to those in adults. The doses: 4 and 8mg 
were well tolerated.
ANTIMUSCARINICS ?
Propiverine
» In some countries approved for use in children
» Recommended daily doses: 0,8 mg/kg body 
weight
» Marschall-Kehrel et al: overactive bladder in 
children aged 5-10 year
• Good tolerability
• Superior to placebo
» Madersbacher et al: neurogenic detrusor 
overactivity
• Better tolerated then oxybutinin
• As effective as oxybutinin
ANTIMUSCARINICS + CALIUM CHANNEL MODULATING
• Selective stimulation of β-receptors:
– Mirabegron:
• β3-adrenergic receptor agonist
• Not approved in children
• Minimal adverse events:
– tachycardia
NEW KID ON THE BLOCK
• LUTS
• In the past
– Vesicocentric vision: the 
bladder as the centre of all 
evils when it comes to 
voiding problems
• At present
– Neurocentric vision: the 
central nervous system as the 
primary site for most LUTS in 
children
EVOLUTION
Only Oxybutinin FDA approved
Large choice of ‘off label’
Very limited evidence in children
Be aware of dosages
CONCLUSION
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